GlobeNewsWire
06 Dec 2025, 19:00 UTC · 45w ago
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
Verdict
Headline takes no side. We score EVAX +0.80 — strongly bullish.
- Expected · EVAX
+0.80strongly bullish
−1 bearish0bullish +1More positive than 90% of ticker scores this week
- Actual





